The new Trump administration could put a stop to pending litigation on the abortion pill mifepristone and other federal abortion policies through changes at the Department of Health and Human Services, according to a top anti-abortion lawyer involved in several pending cases.
Erin Morrow Hawley, senior counsel for the religious legal advocacy firm Alliance Defending Freedom, told the Washington Examiner in an exclusive interview that she is hopeful that Robert F. Kennedy Jr., President Donald Trump’s nominee for HHS secretary, will swiftly resume the anti-abortion policies of Trump’s first term.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.